425 related articles for article (PubMed ID: 32822826)
1. Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression.
Jena BC; Das CK; Bharadwaj D; Mandal M
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188416. PubMed ID: 32822826
[TBL] [Abstract][Full Text] [Related]
2. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
4. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC.
Heenatigala Palliyage G; Samart P; Bobbala S; Rojanasakul LW; Coyle J; Martin K; Callery PS; Rojanasakul Y
Lung Cancer; 2023 Jul; 181():107258. PubMed ID: 37245409
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells.
Sazeides C; Le A
Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782
[TBL] [Abstract][Full Text] [Related]
8. Functional diversity of cancer-associated fibroblasts in modulating drug resistance.
Bu L; Baba H; Yasuda T; Uchihara T; Ishimoto T
Cancer Sci; 2020 Oct; 111(10):3468-3477. PubMed ID: 33044028
[TBL] [Abstract][Full Text] [Related]
9. Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy.
Khan GJ; Sun L; Khan S; Yuan S; Nongyue H
Curr Drug Targets; 2018; 19(13):1573-1588. PubMed ID: 29468965
[TBL] [Abstract][Full Text] [Related]
10. Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy.
Kadel D; Zhang Y; Sun HR; Zhao Y; Dong QZ; Qin LX
Cell Biol Toxicol; 2019 Oct; 35(5):407-421. PubMed ID: 30680600
[TBL] [Abstract][Full Text] [Related]
11. Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer.
Mishra D; Banerjee D
Cells; 2023 Feb; 12(4):. PubMed ID: 36831295
[TBL] [Abstract][Full Text] [Related]
12. Role of miRNAs in cell signaling of cancer associated fibroblasts.
Eichelmann AK; Matuszcak C; Hummel R; Haier J
Int J Biochem Cell Biol; 2018 Aug; 101():94-102. PubMed ID: 29807095
[TBL] [Abstract][Full Text] [Related]
13. Targeting Metabolic Cross Talk between Cancer Cells and Cancer-Associated Fibroblasts.
Jung JG; Le A
Adv Exp Med Biol; 2018; 1063():167-178. PubMed ID: 29946783
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the functions of cancer-associated fibroblasts to therapeutically target head and neck cancer microenvironment.
Prieto-Fernández L; Montoro-Jiménez I; de Luxan-Delgado B; Otero-Rosales M; Rodrigo JP; Calvo F; García-Pedrero JM; Álvarez-Teijeiro S
Biomed Pharmacother; 2023 May; 161():114502. PubMed ID: 37002578
[TBL] [Abstract][Full Text] [Related]
15. Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.
Chan JSK; Sng MK; Teo ZQ; Chong HC; Twang JS; Tan NS
Oncogene; 2018 Jan; 37(2):160-173. PubMed ID: 28892046
[TBL] [Abstract][Full Text] [Related]
16. Active autophagy in cancer-associated fibroblasts: Recent advances in understanding the novel mechanism of tumor progression and therapeutic response.
Jena BC; Rout L; Dey A; Mandal M
J Cell Physiol; 2021 Nov; 236(11):7887-7902. PubMed ID: 34008184
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
18. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.
Li Z; Sun C; Qin Z
Theranostics; 2021; 11(17):8322-8336. PubMed ID: 34373744
[TBL] [Abstract][Full Text] [Related]
19. The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance.
Chandra Jena B; Sarkar S; Rout L; Mandal M
Cancer Lett; 2021 Nov; 520():222-232. PubMed ID: 34363903
[TBL] [Abstract][Full Text] [Related]
20. Cancer associated fibroblasts: phenotypic and functional heterogeneity.
Patel AK; Singh S
Front Biosci (Landmark Ed); 2020 Mar; 25(5):961-978. PubMed ID: 32114420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
